CLINICAL_TRIALS
research
· 2025-07-03
Clinical Trial Update: Evaluation of the NaviFUS System in Drug Resistant Epilepsy [NA]
Summary
Clinical trials registry update showing the NaviFUS System is being evaluated for drug-resistant epilepsy, including temporal lobe epilepsy, with recruitment on…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genovate-NaviFUS (Australia) Pty Ltd. | Conditions: Epilepsy, Temporal Lobe, Drug Resistant Epilepsy | NA | Status: RECRUITING